Successfully reported this slideshow.
Opportunistic mycoses
Dr. Pendru Raghunath Reddy
Opportunistic mycoses
Occurrs in human’s with a compromised immune system

Causative agents are normal resident flora th...
Causative agents
• Candida species
• Cryptococcus neoformans
• Aspergillus species
• Zygomycosis (Rhizopus, mucor, absidia...
Aspergillosis
• Aspergillus species are ubiquitous saprophytes in
nature
• In nature >300 species of Aspergillus exist, fe...
Pathogenesis
This mold produces abundant small conidia that are easily
aerosolized
Following inhalation of these conidia...
Fungal spores enters through respiratory
tract
The Aspergillus species can cause a variety of clinical
syndromes

1. Pulmonary aspergillosis
a) Allergic asthma

b) Bronc...
Allergic asthma
In some atopic individuals, development of IgE antibodies to
the surface antigens of Aspergillus conidia e...
Aspergilloma
• Fungus colonize preexisting
(Tuberculosis ) cavities in
the lung and form compact
ball of mycelium which is...
Invasive aspergillosis
In invasive aspergillosis, the fungus first causes pneumonia,
actively invades the lung tissue and...
Superficial infections
1. Sinusitis
2. Mycotic keratitis
3. Otomycosis
Laboratory diagnosis
Specimens
Sputum, other respiratory specimens, lung biopsy specimens

Microscopic examination

KOH mo...
Culture
Aspergillus species grow readily on SDA without
cycloheximide at 25-370C
Colonies appear after 1-2 days of incub...
Treatment
Invasive aspergillosis is treated with intravenous
amphotericin B
In recent years, intravenous formulations of...
Zygomycosis
Also called as Mucormycosis, Phycomycosis
It is an invasive disease caused by zygomycetes, principally
by th...
Clinical manifestations
There are a number of different clinical varieties of
mucormycosis

1. Rhinocerebral Mucormycosis
...
Rhinocerebral Mucormycosis
Results from germination of the sporangiospores in the
nasal passages and invasion of the hyph...
Thoracic Mucormycosis
This follows inhalation of the sporangiospores with invasion
of the lung parenchyma and vasculature...
Laboratory diagnosis
Secimens
Nasal discharge, sputum and biopsy specimens

Microscopy
KOH mount, may reveal the charact...
Broad, aspetate hyphae in tissue sections
Culture
The fungi are readily isolated on SDA with antibiotics
without cycloheximide, producing abundant cottony
colonies...
Mucor
Treatment
Intravenous amphotericin B combined, where appropriate
with surgical drainage
Penicillosis
There are more than 150 species; most important species
Penicillium marneffei
Penicillium marneffei –therma...
Pathogenesis and clinical features
P. marneffei has been reported to be an important
opportunistic pathogen in the HIV in...
Laboratory diagnosis
The yeast are small, oval, 2-4 µm in diameter
The mycelia form produces red diffusible pigment and
...
www.freelivedoctor.com
Dimorphic chaterization of
Pencillium marneffei
Mycelial growth of P. marneffei Microscopic examination
Treatment
Penicillosis can be treated with amphotericin B and followed
by oral itraconazole
Opportunistic mycoses
Opportunistic mycoses
Opportunistic mycoses
Opportunistic mycoses
Opportunistic mycoses
Upcoming SlideShare
Loading in …5
×

Opportunistic mycoses

2,436 views

Published on

Published in: Education
  • Be the first to comment

Opportunistic mycoses

  1. 1. Opportunistic mycoses Dr. Pendru Raghunath Reddy
  2. 2. Opportunistic mycoses Occurrs in human’s with a compromised immune system Causative agents are normal resident flora that become pathogenic only when the host's immune defenses are altered, as in immunosuppressive therapy, in a chronic disease, such as diabetes mellitus, or during steroid or antibacterial therapy that upsets the balance of bacterial flora in the body
  3. 3. Causative agents • Candida species • Cryptococcus neoformans • Aspergillus species • Zygomycosis (Rhizopus, mucor, absidia) • Penicillium species • Fusarium species • Alternaria species ***ANY fungus found in nature may give rise to opportunistic mycoses ***
  4. 4. Aspergillosis • Aspergillus species are ubiquitous saprophytes in nature • In nature >300 species of Aspergillus exist, few are important as human pathogens • • • • • 1 A.fumigatus 2 A.niger 3 A.flavus 4 A.terreus 5 A.nidulans
  5. 5. Pathogenesis This mold produces abundant small conidia that are easily aerosolized Following inhalation of these conidia, atopic individuals often develop severe allergic reactions to the conidial antigens In immunocompromised patients, the conidia may germinate to produce hyphae that invade the lungs and other tissues
  6. 6. Fungal spores enters through respiratory tract
  7. 7. The Aspergillus species can cause a variety of clinical syndromes 1. Pulmonary aspergillosis a) Allergic asthma b) Bronchopulmonary aspergillosis c) Aspergilloma 2. Invasive aspergillosis 3. Superficial infections
  8. 8. Allergic asthma In some atopic individuals, development of IgE antibodies to the surface antigens of Aspergillus conidia elicits an immediate asthmatic reaction upon subsequent exposure Bronchopulmonary aspergillosis  The conidia germinate and hyphae colonize the bronchial tree without invading the lung parenchyma  The condition is made worse by the development of hypersensitivity to the fungus
  9. 9. Aspergilloma • Fungus colonize preexisting (Tuberculosis ) cavities in the lung and form compact ball of mycelium which is later surrounded by dense fibrous wall presents with cough, sputum production • Haemoptysis occurs due to invasion of blood vessels • Cases of aspergilloma rarely become invasive
  10. 10. Invasive aspergillosis In invasive aspergillosis, the fungus first causes pneumonia, actively invades the lung tissue and disseminates to involve other organs, for example, the brain, kidneys or heart This form occurs in severly immuno compromised individuals who have a serious underlying illness Neutropenia is the most common predisposing factor and A. fumigatus is the species most frequently involved
  11. 11. Superficial infections 1. Sinusitis 2. Mycotic keratitis 3. Otomycosis
  12. 12. Laboratory diagnosis Specimens Sputum, other respiratory specimens, lung biopsy specimens Microscopic examination KOH mount The fungus appears as non-pigmented septate mycelium, 3-5 µm in diameter with chatracteristic dichotomous branching and an irregular outline Rarely the characteristic sporing heads of Aspergillus species are present
  13. 13. Culture Aspergillus species grow readily on SDA without cycloheximide at 25-370C Colonies appear after 1-2 days of incubation Species are identified according to the morphology of their conidial structures Skin tests Skin tests with Aspergillus species antigen are useful for the diagnosis of allergic broncho pulmonary aspergillosis
  14. 14. Treatment Invasive aspergillosis is treated with intravenous amphotericin B In recent years, intravenous formulations of azoles, such as voriconazole, are being evaluated
  15. 15. Zygomycosis Also called as Mucormycosis, Phycomycosis It is an invasive disease caused by zygomycetes, principally by the species of Rhizopus, Mucor, Rhizomucor, Absidia These fungi are ubiquitous theromtolerant saprophyte; spores are present in air and dust The conditions that place patients at risk include acidosis, leukemias, lymphoma, corticosteroid treatment, severe burns, immunodeficiencies
  16. 16. Clinical manifestations There are a number of different clinical varieties of mucormycosis 1. Rhinocerebral Mucormycosis 2. Thoracic Mucormycosis 3. Other sites of invasion
  17. 17. Rhinocerebral Mucormycosis Results from germination of the sporangiospores in the nasal passages and invasion of the hyphae into the blood vessels, causing thrombosis, infarction and necrosis The disease can progress rapidly with invasion of the sinuses, eyes, cranial bones and brain Blood vessels and nerves are damaged, and patients develop edema of the involved facial area, a bloody nasal exudate, and orbital cellulitis It is almost invariably associated with acute diabetes mellitus or with debilitating diseases such as leukemia or lymphoma
  18. 18. Thoracic Mucormycosis This follows inhalation of the sporangiospores with invasion of the lung parenchyma and vasculature In both locations, ischemic necrosis causes massive tissue destruction Other sites of invasion Primary cutaneous infections such as skin infections following burns or surgery have also been reported Subcutaneous zygomycosis cases are also reported
  19. 19. Laboratory diagnosis Secimens Nasal discharge, sputum and biopsy specimens Microscopy KOH mount, may reveal the characteristic broad, aseptate, branched mycelium and sometimes distorted hyphae They are seen much more clearly when stained with methenamine-silver stain The hyphae of these fungi do not stain with PAS
  20. 20. Broad, aspetate hyphae in tissue sections
  21. 21. Culture The fungi are readily isolated on SDA with antibiotics without cycloheximide, producing abundant cottony colonies Identification of the species is based on the sporangial structures
  22. 22. Mucor
  23. 23. Treatment Intravenous amphotericin B combined, where appropriate with surgical drainage
  24. 24. Penicillosis There are more than 150 species; most important species Penicillium marneffei Penicillium marneffei –thermally dimorphic fungi Penicillium species are saprophytes; present in the environment and grow on various substrates such as bread, jam, fruit and cheese
  25. 25. Pathogenesis and clinical features P. marneffei has been reported to be an important opportunistic pathogen in the HIV infected It causes disseminated infection with multiple organ involvement
  26. 26. Laboratory diagnosis The yeast are small, oval, 2-4 µm in diameter The mycelia form produces red diffusible pigment and morphologically resembles other members of the Penicillium species Penicillum species possess septate hyphae with branched conidiophores, with two rows of sterigmata bearing chains of rows; the appearance is like a brush or broom
  27. 27. www.freelivedoctor.com
  28. 28. Dimorphic chaterization of Pencillium marneffei
  29. 29. Mycelial growth of P. marneffei Microscopic examination
  30. 30. Treatment Penicillosis can be treated with amphotericin B and followed by oral itraconazole

×